|
|
|
|
|
by gidorah
980 days ago
|
|
I am a UK accountant. To my knowledge, under IFRS you cannot put IP on your own balance sheet. If you're bought by another company, it goes on the balance sheet as "goodwill" which is the difference between the price paid and the book value of net assets. R&D spend is pure cost to the business. There might be tax advantages to doing it (UK has some addital tax benefits), but broadly just hits the income statement. I'm pretty sure that USGAAP has similar rules, however, I would apply a health warning to what I've said. |
|
source code or patents are actual hard assets regardless of whatever rules were made up. it is typical for bankers or acountants to dismiss the assets engineers create. imagine engineers did the same and reason that bonds are worthless because it is just paper or that your client base is worth nothing?
if you do not put IP on your balance sheet and keep expensing it eventually you end up with negative net worth which makes your business look very unattractive and unhealthy. been there done that. if you incurr expenses and in return create an asset it should be on the balance sheet. i cannot imagine diamond mining operations not putting the diamonds on the balance sheet….